CN100352821C - 一种瑞舒伐他汀钙中间体的制备方法 - Google Patents
一种瑞舒伐他汀钙中间体的制备方法 Download PDFInfo
- Publication number
- CN100352821C CN100352821C CNB2005100442879A CN200510044287A CN100352821C CN 100352821 C CN100352821 C CN 100352821C CN B2005100442879 A CNB2005100442879 A CN B2005100442879A CN 200510044287 A CN200510044287 A CN 200510044287A CN 100352821 C CN100352821 C CN 100352821C
- Authority
- CN
- China
- Prior art keywords
- tms
- methyl
- oxygen
- fluorophenyl
- pyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100442879A CN100352821C (zh) | 2005-08-22 | 2005-08-22 | 一种瑞舒伐他汀钙中间体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100442879A CN100352821C (zh) | 2005-08-22 | 2005-08-22 | 一种瑞舒伐他汀钙中间体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1733774A CN1733774A (zh) | 2006-02-15 |
CN100352821C true CN100352821C (zh) | 2007-12-05 |
Family
ID=36076416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100442879A Active CN100352821C (zh) | 2005-08-22 | 2005-08-22 | 一种瑞舒伐他汀钙中间体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100352821C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007022488A2 (en) | 2005-08-16 | 2007-02-22 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260440A (en) * | 1991-07-01 | 1993-11-09 | Shionogi Seiyaku Kabushiki Kaisha | Pyrimidine derivatives |
CN1340052A (zh) * | 1999-02-17 | 2002-03-13 | 阿斯特拉曾尼卡有限公司 | (e)-(6-{2-[4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰基)氨基]嘧啶-5-基]乙烯基}(4r,6s)-2,2,-二甲基[1,3]二氧杂-4-基)乙酸叔丁酯的制备方法 |
-
2005
- 2005-08-22 CN CNB2005100442879A patent/CN100352821C/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260440A (en) * | 1991-07-01 | 1993-11-09 | Shionogi Seiyaku Kabushiki Kaisha | Pyrimidine derivatives |
CN1340052A (zh) * | 1999-02-17 | 2002-03-13 | 阿斯特拉曾尼卡有限公司 | (e)-(6-{2-[4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰基)氨基]嘧啶-5-基]乙烯基}(4r,6s)-2,2,-二甲基[1,3]二氧杂-4-基)乙酸叔丁酯的制备方法 |
Non-Patent Citations (2)
Title |
---|
HMG-CoA还原酶抑制剂的合成 蔡正艳等.中国医药工业杂志,第35卷第10期 2004 * |
HMG-CoA还原酶抑制剂的合成 蔡正艳等.中国医药工业杂志,第35卷第11期 2004 * |
Also Published As
Publication number | Publication date |
---|---|
CN1733774A (zh) | 2006-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2853227B2 (ja) | 7置換‐ヘプト‐6‐エン酸、ヘプタン酸及び誘導体並びにそれらの中間体の製法 | |
US8212034B2 (en) | Process for preparing rosuvastatin calcium | |
TW200831469A (en) | Chemical process | |
EP2602250B1 (en) | Method for preparing rosuvastatin calcium intermediate | |
WO2006106526A1 (en) | Process for preparation of calcium salt of rosuvastatin | |
US7812179B2 (en) | Process for the preparation of atorvastatin and intermediates | |
CN100352821C (zh) | 一种瑞舒伐他汀钙中间体的制备方法 | |
JP5301676B2 (ja) | (3s,4s)−4−((r)−2−(ベンジルオキシ)トリデシル)−3−ヘキシル−2−オキセタノンの製造方法及びそれに用いられる新規な中間体 | |
JP4820965B2 (ja) | スタチン、特にアトルバスタチンの調製において有用な方法および中間体化合物 | |
KR20100052230A (ko) | 피타바스타틴 중간체의 제조방법 및 이를 이용한 피타바스타틴 헤미 칼슘염의 제조방법 | |
CN1105996A (zh) | 咪唑并吡啶类衍生物的制备方法 | |
KR101528359B1 (ko) | 스타틴 화합물 제조를 위한 신규한 보로네이트 에테르 화합물, 그 제조방법 및 상기 보로네이트 에테르 화합물을 이용한 스타틴 화합물 제조방법 | |
JP5796836B2 (ja) | ピタバスタチンまたはその塩の中間体の製造方法 | |
Wang et al. | Asymmetric synthesis of β, β-difluoroamino acids via cross-coupling and Strecker reactions | |
KR20070048741A (ko) | 디아릴사이클로알킬 유도체의 제조방법 | |
CN103360384A (zh) | HMG-CoA还原酶抑制剂关键中间体的合成方法 | |
JP2009516728A (ja) | 方法と化合物 | |
KR20090104253A (ko) | 아토르바스타틴의 제조방법, 이에 사용되는 중간체 화합물및 이들의 제조방법 | |
JP4867071B2 (ja) | キノリン誘導体の製造方法 | |
JP4330783B2 (ja) | ホルミルシクロプロパンカルボン酸エステルの製造方法 | |
KR20110134249A (ko) | 피타바스타틴 또는 그의 염의 중간체의 제조방법 | |
EP0204287A2 (en) | Process for the preparation of HMG-CoA reductase inhibitors with a 3,5-Dihydroxypentanoate subunit | |
JPH08208618A (ja) | 4a−アリ−ルデカヒドロイソキノリン類の製造法 | |
JPH082822B2 (ja) | 置換フェノキシアルキルアルデヒドジアルキルアセタ−ル類およびその製造方法 | |
JP2018095561A (ja) | ジフェニルアゼチジン誘導体の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20060215 Assignee: Lunan Beite Pharmaceutical Co., Ltd. Assignor: Lunan Pharmaceutical Group Co., Ltd. Contract record no.: 2013370000261 Denomination of invention: Method for preparing rosuvastatin calcium intermediate Granted publication date: 20071205 License type: Exclusive License Record date: 20131210 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Guimin Inventor after: Zhang Lixing Inventor after: Wang Benli Inventor after: Zhao Zhiquan Inventor after: Peng Lizeng Inventor after: Di Fumin Inventor before: Zhao Zhiquan Inventor before: Peng Lizeng Inventor before: Di Fumin |
|
COR | Change of bibliographic data |